Quantcast

Latest Carotid stenting Stories

2014-07-23 08:31:14

SUNNYVALE, Calif., July 23, 2014 /PRNewswire/ -- Silk Road Medical, Inc., a developer of advanced devices for the transcarotid treatment of intra- and extra-cranial cerebrovascular disease, announced today the appointment of Michael P. Wallace to the position of Chief Technology Officer. In this new role, Michael will lead the company's Research and Development efforts across its family of transcarotid access and treatment devices. Prior to joining Silk Road Medical, Michael was...

2014-07-16 16:23:43

- Novel Transcarotid Flow Reversal and Stent Procedure Uses Best Elements of the Surgical and Endovascular Approaches SUNNYVALE, Calif., July 16, 2014 /PRNewswire/ -- Silk Road Medical, Inc. announced today the completion of enrollment in its pivotal ROADSTER study. The trial was the first of its kind to study the treatment of carotid artery stenosis by placing a stent via direct access to the common carotid artery in the neck in an entirely new minimally invasive procedure. The...

2014-07-08 08:31:38

100% procedural success rate achieved in first multi-specialty clinical experience BOSTON, July 8, 2014 /PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced that it has concluded enrollment in its CARENET clinical trial. The multi-specialty (Interventional Cardiologists, Interventional Radiologists and Vascular Surgeons) trial is assessing the peri-procedural safety and efficacy of CGuard...

2014-03-19 08:30:26

Proven Embolic Protection System Expands to Treat Carotid Artery Disease BOSTON, March 19, 2014 /PRNewswire/ -- InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems, today announced that it has successfully enrolled the first patient into the CARENET (CARotid Embolic protection study using microNET) multi-center European clinical trial for the new CGuard(TM) carotid embolic protection system. The CARENET clinical study is a...

2014-02-13 12:26:58

Aortic Stent Grafts Will Continue To Generate the Majority of Revenues Due To Strong Acceptance in the Thoracic Indication, According to Decision Research Group BURLINGTON, Mass., Feb. 13, 2014 /PRNewswire/ -- Decision Resources Group finds that the Chinese peripheral vascular (PV) device market will grow strongly through 2022 as patients in China increasingly seek treatment for PV disease. Historically, awareness of the disease among patients and physicians was low, resulting in a...

2014-01-13 08:28:13

SUNNYVALE, Ca., Jan. 13, 2014 /PRNewswire/ -- Silk Road Medical, Inc., a developer of advanced devices for the treatment of Carotid Artery disease, announced today the appointment of Sumaira Macdonald, MD, PhD to the position of Chief Medical Officer effective immediately. In this new role, Dr. Macdonald will direct the company's scientific and technical agenda and lead research in ground breaking endovascular interventions for the prevention and treatment of stroke. Prior to...

2013-10-28 11:37:53

The final results of a stroke prevention study in patients with narrowed brain arteries confirm earlier findings: Medication plus lifestyle changes are safer and more effective at preventing stroke than a surgical technique called stenting. Enrollment in the trial was halted two years ago when it became apparent that stenting was associated with a higher risk of early strokes and death. "Surgical interventions often have increased risk of complications early on, so we continued to...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related